This topic contains a solution. Click here to go to the answer
« previous next »

Author Question: Medications that degrade polymers in secretions are a. mucokinetics. b. mucolytics. c. ... (Read 73 times)

sabina

  • Hero Member
  • *****
  • Posts: 563
on: Jul 16, 2018
Medications that degrade polymers in secretions are
 
  a. mucokinetics.
  b. mucolytics.
  c. mucoregulatory agents.
  d. expectorants.

Question 2

When should mucoactive therapy be considered?
 
  a. Before inhaled corticosteroids are administered
  b. When an active upper respiratory infection is causing bronchospasm
  c. After therapy to decrease infection and inflammation
  d. Only during mechanical ventilation of a patient with COPD


Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

asdfasdf

  • Sr. Member
  • ****
  • Posts: 339
Reply #1 on: Jul 16, 2018
Answer to Question 1

ANS: B

Answer to Question 2

ANS: C


sabina

  • Member
  • Posts: 563
Reply 2 on: Jul 16, 2018
Excellent

jamesnevil303

  • Member
  • Posts: 337
Reply 3 on: Yesterday
Great answer, keep it coming :)

« previous next »
 

Did you know?

Methicillin-resistant Staphylococcus aureus or MRSA was discovered in 1961 in the United Kingdom. It if often referred to as a superbug. MRSA infections cause more deaths in the United States every year than AIDS.

Methicilli ...
Did you know?

About 100 new prescription or over-the-counter drugs come into the U.S. market every year.

Did you know?

Most strokes are caused when blood clots move to a blood vessel in the brain and block blood flow to that area. Thrombolytic therapy can be used to dissolve the clot quickly. If given within 3 hours of the first stroke symptoms, this therapy can help limit stroke damage and disability.

Did you know?

The familiar sounds of your heart are made by the heart's valves as they open and close.

Did you know?

Lower drug doses for elderly patients should be used first, with titrations of the dose as tolerated to prevent unwanted drug-related pharmacodynamic effects.

Asthma. (a) A normal bronchiole. (b) An asthmatic bronchiole. During an asthma “attack,” the bronchi Asthma. (a) A normal bronchiole. (b) An asthmatic bronchiole. During an asthma “attack,” the bronchi
Examples of specimen collection containers for stool, urine, and swabs for wounds or secretions. Examples of specimen collection containers for stool, urine, and swabs for wounds or secretions.
Older adults may need special assistance with medications. Older adults may need special assistance with medications.
Topical medications come in a variety of forms. Topical medications come in a variety of forms.
(A) Nebulizer and (B) inhaler medication delivery devices for asthma medications. (A) Nebulizer and (B) inhaler medication delivery devices for asthma medications.
Long Term Control Medications Long Term Control Medications
Video: Asthma Treatment

For a complete list of videos, visit our video library